Crystal structure of crosslink stabilized long-form PDE4B | | homo-2-mer | 166-657 | 3×ZN; 2×NA; 2×MG; 2×IOD; |
Assess |
Crystal structure of crosslink stabilized long-form PDE4B in complex with (R)-(-)-rolipram | | homo-2-mer | 166-657 | 3×ZN; 2×IOD; 2×ROL; 2×MG; |
Assess |
Crystal structure of human phosphodiesterase 4b with regulatory domain and d155988 | | homo-2-mer | 247-658 | 2×ZN; 2×MG; 2×988; |
Assess |
Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor | | homo-2-mer | 325-659 | 2×SK4; 2×ZN; 2×MG; 6×ARS; 4×GOL; |
Assess |
Catalytic domain of human phosphodiesterase 4B2B in complex with a tetrahydrobenzothiophene inhibit… | | monomer | 324-683 | 1×ZN; 1×MG; 1×HBT; 1×GOL; |
Assess |
Crystal structure of phosphodiesterase 4B in complex with compound 31e | | monomer | 326-683 | 1×NVW; 1×ZN; 1×CA; |
Assess |
Crystal structure of phosphodiesterase 4B in complex with compound 10f | | monomer | 326-683 | 1×QPC; 1×ZN; 1×CA; |
Assess |
CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B | | monomer | 324-680 | 1×ZN; 1×MG; 3×ARS; |
Assess |
Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33 | | monomer | 324-680 | 1×19T; 1×MG; 1×ZN; 1×NA; 3×EDO; |
Assess |
PDE4 catalytic domain | | monomer | 324-680 | 1×ZN; 1×MG; 1×NA; 1×2O5; 6×EDO; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Mesopram | | monomer | 335-685 | 1×ZN; 1×MG; 1×5RM; |
Assess |
Crystal structure of human PDE4b with 5-[3-[(1S,2S,4R)-Bicyclo[2.2.1]hept-2-yloxy]-4-methoxyp henyl… | | monomer | 335-681 | 1×ZN; 1×0CP; 1×MG; |
Assess |
Crystal structure of PDE4B2B complexed with Rolipram (R & S) | | monomer | 324-667 | 1×ZN; 1×MN; 1×ARS; 1×ROL; |
Assess |
CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP | | monomer | 324-661 | 2×ZN; 1×AMP; |
Assess |
CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-Br-AMP | | monomer | 324-661 | 2×ZN; 1×8BR; |
Assess |
Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001 | | monomer | 323-659 | 1×ZN; 1×MG; 3×ACT; 1×6M5; |
Assess |
Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor. | | monomer | 323-658 | 1×ZN; 1×MG; 1×9VE; |
Assess |
Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor | | monomer | 324-659 | 1×066; 1×ZN; 1×MG; 4×ARS; 3×GOL; |
Assess |
Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitor | | monomer | 324-659 | 1×ZN; 1×MG; 1×20A; 3×ARS; |
Assess |
PDE4B bound to MAPI compound 92a | | monomer | 323-658 | 1×ZN; 1×MG; 1×VL9; |
Assess |
Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i… | | monomer | 324-659 | 1×ZN; 1×MG; 3×ARS; 1×ZG2; 1×GOL; |
Assess |
Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i… | | monomer | 325-659 | 1×ZN; 1×MG; 3×ARS; 1×ZG1; 2×GOL; |
Assess |
Crystal structure of PDE4B2B in complex with inhibitor NPV | | monomer | 324-657 | 1×ZN; 2×MG; 1×NPV; |
Assess |
Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitor | | monomer | 324-657 | 1×Z72; 1×ZN; 1×MG; 1×SO4; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Roflumilast | | monomer | 327-657 | 1×ZN; 1×MG; 1×ROF; |
Assess |
Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivative | | monomer | 334-657 | 1×1S1; 1×MG; 1×ZN; 19×EDO; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil | | monomer | 334-657 | 1×ZN; 1×MG; 1×SO4; 1×VIA; |
Assess |
Human Phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor | | monomer | 334-656 | 1×ZN; 1×MG; 1×6QQ; 17×EDO; |
Assess |
PDE4B In complex with ligand an2898 | | monomer | 334-656 | 1×ZN; 1×MG; 1×3OJ; 14×EDO; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminast | | monomer | 335-657 | 1×ZN; 1×MG; 1×FIL; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With AMP | | monomer | 335-657 | 1×ZN; 1×MG; 1×AMP; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilast | | monomer | 335-657 | 1×ZN; 1×MG; 1×CIO; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R,S)-Rolipram | | monomer | 335-657 | 1×ZN; 1×MG; 2×ROL; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Piclamilast | | monomer | 335-657 | 1×ZN; 1×MG; 1×PIL; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafil | | monomer | 335-657 | 1×ZN; 1×MG; 1×VDN; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 1-(2-chloro-phenyl)-3,5-dimethyl-1H-… | | monomer | 335-657 | 1×ZN; 1×MG; 1×6DE; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Rolipram | | monomer | 335-657 | 1×ZN; 1×MG; 1×ROL; |
Assess |
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p… | | monomer | 335-657 | 1×ZN; 1×MG; 1×7DE; |
Assess |
Crystal structure of N2 substituted pyrazolo pyrimidinones - a flipped binding mode in PDE5 | | monomer | 451-476 | 1×ZN; 1×MG; 1×3P4; 1×MES; |
Assess |
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004 | | monomer | 663-673 | 2×ZN; 1×MG; 1×E31; 1×CL; |
Assess |